MCID: STM003
MIFTS: 17

Stomach Carcinoma in Situ

Categories: Cancer diseases, Genetic diseases, Rare diseases, Gastrointestinal diseases

Aliases & Classifications for Stomach Carcinoma in Situ

MalaCards integrated aliases for Stomach Carcinoma in Situ:

Name: Stomach Carcinoma in Situ 12 14
Carcinoma in Situ of Stomach 12 69
Gastric Carcinoma in Situ 12

Classifications:



External Ids:

Disease Ontology 12 DOID:9138
ICD10 32 D00.2
ICD9CM 34 230.2
NCIt 46 C7788
SNOMED-CT 64 189223002 92756002
UMLS 69 C0154060

Summaries for Stomach Carcinoma in Situ

MalaCards based summary : Stomach Carcinoma in Situ, also known as carcinoma in situ of stomach, is related to lip carcinoma in situ and esophagus carcinoma in situ. An important gene associated with Stomach Carcinoma in Situ is CRLF1 (Cytokine Receptor Like Factor 1). The drugs Paclitaxel and Oxaliplatin have been mentioned in the context of this disorder.

Related Diseases for Stomach Carcinoma in Situ

Diseases in the Familial Stomach Cancer family:

Stomach Carcinoma in Situ

Diseases related to Stomach Carcinoma in Situ via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 lip carcinoma in situ 10.3
2 esophagus carcinoma in situ 10.3

Comorbidity relations with Stomach Carcinoma in Situ via Phenotypic Disease Network (PDN):


Gastric Cancer

Symptoms & Phenotypes for Stomach Carcinoma in Situ

Drugs & Therapeutics for Stomach Carcinoma in Situ

Drugs for Stomach Carcinoma in Situ (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Paclitaxel Approved, Vet_approved Phase 1 33069-62-4 36314
2
Oxaliplatin Approved, Investigational Phase 1 61825-94-3 43805 6857599 5310940 9887054
3
Tegafur Approved, Investigational Phase 1 17902-23-7 5386
4
Levoleucovorin Approved, Investigational Phase 1 68538-85-2
5
leucovorin Approved, Nutraceutical Phase 1 58-05-9 143 6006
6
Folic Acid Approved, Nutraceutical, Vet_approved Phase 1 59-30-3 6037
7
s 1 (combination) Phase 1
8 Albumin-Bound Paclitaxel Phase 1
9 Antimetabolites Phase 1
10 Antimetabolites, Antineoplastic Phase 1
11 Antimitotic Agents Phase 1
12 Antineoplastic Agents, Phytogenic Phase 1
13 Folate Nutraceutical Phase 1
14 Vitamin B9 Nutraceutical Phase 1

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers Not yet recruiting NCT03162510 Phase 1 Oxaliplatin;Albumin-Bound Paclitaxel /nab-Paclitaxel;S-1;LV

Search NIH Clinical Center for Stomach Carcinoma in Situ

Genetic Tests for Stomach Carcinoma in Situ

Anatomical Context for Stomach Carcinoma in Situ

Publications for Stomach Carcinoma in Situ

Variations for Stomach Carcinoma in Situ

Expression for Stomach Carcinoma in Situ

Search GEO for disease gene expression data for Stomach Carcinoma in Situ.

Pathways for Stomach Carcinoma in Situ

GO Terms for Stomach Carcinoma in Situ

Sources for Stomach Carcinoma in Situ

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....